Skip to content
    Morningside logo

    Morningside

    Newton, Massachusetts, United StatesFounded 1986
    morningside.comLinkedIn
    Biotech & Life SciencesHealthcareAIEnterprise Software

    Morningside is a private investment group founded in 1986 by the Chan family of Hong Kong. The firm makes venture capital and private equity investments in companies with novel science and technology, characterized by a long-term outlook in company-building.

    Average disclosed round size is $52.5M (across 159 rounds with reported amounts).

    Find people at Morningside on Goldilocks AI

    Portfolio

    132

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    5

    Team

    KD

    Karl Dunkenberg

    Managing Partner

    PV

    Pavel Velkov

    Partner

    AA

    Anthony Aiudi

    Investor

    DW

    Dan White

    Investor

    JD

    Jason Dinges

    Venture Capital

    JH

    Jawanza Hughes

    Chief Investment Officer

    LS

    Lily Shen

    Healthcare Investment

    SM

    Stephanie Monaghan O'Brien

    Investment Professional

    WN

    Wes Nolin

    Biotech & Healthcare Venture Capital

    EC

    Elijah Chang

    Digital Health VC

    PH

    Peter Hu

    Digital Health VC

    R(

    Ruoxi (Rosy) Hu

    Biotech VC

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    185 investments
    CompanyRoundAmountDate
    Dewey logoDeweySeries A$5MJul 2026
    SimpliFed logoSimpliFedSeries A$10.8MApr 2026
    Ampa Health logoAmpa HealthSeed$8.5MOct 2025
    Brook logoBrookSeries B$28MOct 2025
    CCyted HealthSeries B$44MSep 2025
    Accropeutics Inc. logoAccropeutics Inc.Series B$12MMar 2025
    SimpliFed logoSimpliFedSeed$4MFeb 2025
    Geneoscopy logoGeneoscopySeries C$105MJan 2025
    Alebund logoAlebundSeries C—Jan 2025
    AdvanCell logoAdvanCellSeries C$112MJan 2025
    Cyted logoCytedSeries B$44MJan 2025
    CCyted HealthUnknown$44MJan 2025
    AAlentisSeries D$181.4MNov 2024
    AAlamar Biosciences, Inc.Series C$128MFeb 2024
    FF2GUnknown$100MJan 2024
    FlyteHealth logoFlyteHealthSeries A$24MJan 2024
    FF2GSeries H$100MJan 2024
    Eko Health logoEko HealthSeries C$125MJan 2024
    Alentis Therapeutics logoAlentis TherapeuticsSeries D$181.4MJan 2024
    Jitjatjo logoJitjatjoSeries B$30MDec 2023
    Epigenic logoEpigenicSeries A$32MAug 2023
    Evonetix logoEvonetixSeries B$30MFeb 2023
    AdaptX logoAdaptXSeries A$10MJan 2023
    TransThera Biosciences logoTransThera BiosciencesSeries D$100MJan 2023
    Angitia Biopharmaceuticals logoAngitia BiopharmaceuticalsSeries B$40MJan 2023
    Page 1 of 8

    Top Co-Investors

    General Catalyst16 shared
    OrbiMed12 shared
    Forbion9 shared
    Sofinnova Partners8 shared
    Legend Capital7 shared
    Shunwei Capital6 shared
    BGF6 shared
    Frazier Healthcare Partners6 shared
    Novo Capital6 shared
    Lightspeed Venture Partners5 shared
    Fidelity Investments5 shared
    Boston Seed Capital5 shared
    Visible Ventures5 shared
    Golden Ventures5 shared
    Matrix Partners5 shared
    Polaris Partners5 shared
    International Finance Corporation5 shared
    Hillhouse Investment4 shared
    MPC4 shared
    IDG Capital4 shared

    Last updated: 7 October 2026